Austin Gumbo1, Hillary M Topazian2, Alexis Mwanza2, Cedar L Mitchell2, Sydney Puerto-Meredith2, Ruth Njiko3, Michael Kayange1, David Mwalilino4, Bernard Mvula4, Gerald Tegha3, Tisungane Mvalo3,5, Irving Hoffman3,6, Jonathan J Juliano7. 1. National Malaria Control Programme, Malawi Ministry of Health, Lilongwe, Malawi. 2. Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, USA. 3. University of North Carolina Project-Malawi, Lilongwe, Malawi. 4. National HIV Reference Laboratory, Malawi Ministry of Health, Lilongwe, Malawi. 5. Department of Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA. 6. Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA. 7. Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Abstract
BACKGROUND: Plasmodium falciparum malaria dominates throughout sub-Saharan Africa, but the prevalence of Plasmodium malariae, Plasmodium ovale spp., and Plasmodium vivax increasingly contribute to infection in countries that control malaria using P. falciparum-specific diagnostic and treatment strategies. METHODS: We performed quantitative polymerase chain reaction (qPCR) on 2987 dried blood spots from the 2015-2016 Malawi Demographic and Health Survey to identify presence and distribution of nonfalciparum infection. Bivariate models were used to determine species-specific associations with demographic and environmental risk factors. RESULTS: Nonfalciparum infections had broad spatial distributions. Weighted prevalence was 0.025 (SE, 0.004) for P. malariae, 0.097 (SE, 0.008) for P. ovale spp., and 0.001 (SE, 0.0005) for P. vivax. Most infections (85.6%) had low-density parasitemias ≤ 10 parasites/µL, and 66.7% of P. malariae, 34.6% of P. ovale spp., and 40.0% of P. vivax infections were coinfected with P. falciparum. Risk factors for P. malariae were like those known for P. falciparum; however, there were few risk factors recognized for P. ovale spp. and P. vivax, perhaps due to the potential for relapsing episodes. CONCLUSIONS: The prevalence of any nonfalciparum infection was 11.7%, with infections distributed across Malawi. Continued monitoring of Plasmodium spp. becomes critical as nonfalciparum infections become important sources of ongoing transmission.
BACKGROUND: Plasmodium falciparum malaria dominates throughout sub-Saharan Africa, but the prevalence of Plasmodium malariae, Plasmodium ovale spp., and Plasmodium vivax increasingly contribute to infection in countries that control malaria using P. falciparum-specific diagnostic and treatment strategies. METHODS: We performed quantitative polymerase chain reaction (qPCR) on 2987 dried blood spots from the 2015-2016 Malawi Demographic and Health Survey to identify presence and distribution of nonfalciparum infection. Bivariate models were used to determine species-specific associations with demographic and environmental risk factors. RESULTS: Nonfalciparum infections had broad spatial distributions. Weighted prevalence was 0.025 (SE, 0.004) for P. malariae, 0.097 (SE, 0.008) for P. ovale spp., and 0.001 (SE, 0.0005) for P. vivax. Most infections (85.6%) had low-density parasitemias ≤ 10 parasites/µL, and 66.7% of P. malariae, 34.6% of P. ovale spp., and 40.0% of P. vivax infections were coinfected with P. falciparum. Risk factors for P. malariae were like those known for P. falciparum; however, there were few risk factors recognized for P. ovale spp. and P. vivax, perhaps due to the potential for relapsing episodes. CONCLUSIONS: The prevalence of any nonfalciparum infection was 11.7%, with infections distributed across Malawi. Continued monitoring of Plasmodium spp. becomes critical as nonfalciparum infections become important sources of ongoing transmission.
Authors: Jenny A Walldorf; Lauren M Cohee; Jenna E Coalson; Andy Bauleni; Kondwani Nkanaunena; Atupele Kapito-Tembo; Karl B Seydel; Doreen Ali; Don Mathanga; Terrie E Taylor; Clarissa Valim; Miriam K Laufer Journal: PLoS One Date: 2015-07-24 Impact factor: 3.240
Authors: Manuel W Hetzel; Lisa J Reimer; Gibson Gideon; Gussy Koimbu; Céline Barnadas; Leo Makita; Peter M Siba; Ivo Mueller Journal: Parasit Vectors Date: 2016-06-14 Impact factor: 3.876
Authors: Ross M Boyce; Nick Hathaway; Travis Fulton; Raquel Reyes; Michael Matte; Moses Ntaro; Edgar Mulogo; Andreea Waltmann; Jeffrey A Bailey; Mark J Siedner; Jonathan J Juliano Journal: Sci Rep Date: 2018-07-05 Impact factor: 4.379
Authors: Chris Funk; Pete Peterson; Martin Landsfeld; Diego Pedreros; James Verdin; Shraddhanand Shukla; Gregory Husak; James Rowland; Laura Harrison; Andrew Hoell; Joel Michaelsen Journal: Sci Data Date: 2015-12-08 Impact factor: 6.444
Authors: Hillary M Topazian; Austin Gumbo; Sydney Puerto-Meredith; Ruth Njiko; Alexis Mwanza; Michael Kayange; David Mwalilino; Bernard Mvula; Gerald Tegha; Tisungane Mvalo; Jessie K Edwards; Michael Emch; Audrey Pettifor; Jennifer S Smith; Irving Hoffman; Steven R Meshnick; Jonathan J Juliano Journal: Sci Rep Date: 2020-10-30 Impact factor: 4.379